Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. John Walsh

Associate Professor (Pharmacy)
25/6/7 WESTLAND ROW
      
Profile Photo

Dr. John Walsh

Associate Professor (Pharmacy)
25/6/7 WESTLAND ROW

 jjwalsh@tcd.ie

 3531896 2806


John J. Walsh, BA (Mod.), PhD (TCD), is an Associate Professor of Pharmacognosy and Associate Director of the NatPro Centre for Natural Product Research in Trinity College Dublin. A particular theme of his research is the evaluation of plant-based metabolites for potential use in the treatment of inflammatory conditions, microbial and insect-related infections, allergies and cancer. In parallel, he also runs drug design based projects with particular emphasis on the design, synthesis and evaluation of hybrid-based compounds and designed multiple ligands as potential therapies for both malaria and cancer. As Senior Author he has published widely across many of the leading journals in his field. including Journal of Natural Products, European Journal of Medicinal Chemistry, British Journal of Pharmacology, Bioorganic and Medicinal Chemistry, Angiogenesis, Current Pharmaceutical Design, Pharmaceutical Research, Current Medicinal Chemistry, Pharmaceutics and Chemical Communications. Funding for his research has been secured from Enterprise Ireland, Cancer Research Ireland, Research Ireland, Higher Education Authority and Department of Justice, Ireland. As principal supervisor he has supervised 20 PhD and 4 MSc students to completion. He is a very strong advocate of research-led teaching and has published eight papers in the Journal of Chemical Education on miniaturised and sustainable methods for the isolation of medicinally important natural products. He is a former Director of Undergraduate Teaching and Learning in the School of Pharmacy and Pharmaceutical Sciences and is currently a member of Committee 13B (Phytochemistry) of the European Pharmacopoeia.
  ALLERGY   ASSAY   BASOPHILS   DRUG DISCOVERY   ENDOTHELIAL CELLS   HISTAMINE   MALARIA   MAST-CELLS   NATURAL PRODUCT SYNTHESIS   PROTEASES   VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
Project Title
 Pre-clinical Development of Novel Anti-allergic Compounds
From
Oct 2004
To
Mar 2009
Summary
The work involved synthesis of lead compounds and evaluation of their effects in vitro and in vivo against passive cutaneous anaphylaxis.
Funding Agency
Enterprise Ireland
Programme
EI-CFTD/04/115: Commercialisation Fund Technology Development Phase
Project Type
Allergy Research
Person Months
120
Project Title
 Design of Tumour Homing Vasculature Targeting Agents
From
01-10-2008
To
30-09-2011
Summary
The project involved the synthesis of designed multiple ligands with homing properties to tumour vasculature.
Funding Agency
Irish Research Council for Science Engineering and Technology
Programme
EMBARK Postgraduate Scholarship Scheme 2008
Project Type
Cancer
Person Months
36
Project Title
 Design of Hybrid-based Tumour Homing Anti-angiogenesis Agents
From
01-10-2008
To
30-09-2011
Summary
The purpose of this work was to design, synthesise and evaluate the homing properties of hybrid-based anti cancer compounds.
Funding Agency
Irish Research Council for Science Engineering and Technology
Programme
EMBARK Postgraduate Scholarship Scheme 2008
Project Type
Cancer
Person Months
36
Project Title
 Studies on Novel Mast Cell Stabilising Compounds
From
01-10-2008
To
30-09-2009
Summary
The project involved in vitro and in vivo studies on novel mast cell stabilising compounds.
Funding Agency
Irish Research Council For Science Engineering and Technology
Programme
EMBARK Postgraduate Scholarship Scheme 2008
Project Type
Allergy
Person Months
12
Project Title
 Synthesis and evaluation of tunable cyclolactams for antimalarial therapy
From
Jan. 2004
To
Apr. 2005
Summary
The project involved the synthesis of peptide-based tunable cyclolactams and their in vitro evaluation against Plasmodium falciparum. In collaboration with Dr Angus Bell, Department of Microbiology, TCD.
Funding Agency
Enterprise Ireland
Programme
Proof of Concept
Project Type
Malaria Research
Person Months
16

Page 1 of 2
Details Date
Ireland representative on Committee 13b of the European Pharmacopoeia, Strasbourg. 2016
Details Date From Date To
The Society for Medicinal Plant Research 2022 date
Phytochemical Society of Europe 1998 date
European Histamine Research Society 2002 date
Mark J. Lyons, Brendan Twamley, John J. Walsh, CCDC 2554447: Experimental Crystal Structure Determination, Cambridge Crystallographic Data Centre, 2026, Dataset, PUBLISHED  DOI
Nagar, S., Pigott, M., Kukula-Koch, W., Sheridan, H., & Walsh, J., NMR Data of Lichenic Acids From Irish Cladonia Portentosa, nmrXiv, 2026, Dataset, PUBLISHED  URL
Whyms SE, Sheridan H, Walsh JJ, Design Considerations for Essential Oil Formulations: Emulsification, Encapsulation and Stabilisation Strategies, Pharmaceutics, 18, (8), 2026, p953 - 995, Journal Article, PUBLISHED  DOI
Sophie E. Whyms, Gesine Kroll, Carsten Ehrhardt, Pierce V. Kavanagh 4, Immo A. Hansen, Helen Sheridan and John J. Walsh, Formulation of Glycerol-Based Emulsion Containing Myrica gale L. Essential Oil for Enhanced Repellent Activity, Pharmaceutics, 18, (11), 2026, p1406 - 1427, Journal Article, PUBLISHED  URL
Whyms SE, Nagar S, Luker HA, Lopez AD, Pigott M, Hodkinson TR, Sheridan H, Hansen IA & Walsh JJ, Repellent activity against Aedes aegypti and metabolomic profiling of Myrica gale L. essential oils from Irish boglands, Scientific Reports, 2026, phttps://doi.org/10.1038/s41598 , Journal Article, PUBLISHED  DOI  URL
Scalabrino GA, Walsh JJ, Sheridan H., Natural Products as Health Drivers in the Bioeconomy: BioVal an Integrative Framework for Sustainable High-Value Product Development., Sustainability, 18, (19), 2026, p9911 - 9943, Journal Article, PUBLISHED  DOI
Scalabrino GA, Gafner S, Armbrecht A, Cuerrier A, Cunningham AB, Goi P, Heinrich M, Mulà A, Mundkinajeddu D, Satyal P, Sheridan H., Medicinal Plant Production in a World of Climate Change: Implications for Quality and Long-Term Trade Viability, Planta Medica, 2026, p1 - 21, Journal Article, PUBLISHED  DOI
Ronan R. McCarthy, Kavita Gadar, John Walsh, Wildflower once used to treat wounds and sore throats shows promise in fighting dangerous superbugs, The Conversation, 2026, Journal Article, PUBLISHED  DOI
Kavita Gadar; Maria Pigott; Cillian Jacques Gately; Ismael Obaidi; Shipra Nagar; John J. Walsh; Helen Sheridan; Ronan R McCarthy, Bogland plant Tormentil inhibits multidrug-resistant pathogen growth and potentiates antibiotics by disrupting iron homeostasis, Microbiology (Reading), 172, (3), 2026, p1 - 14, Journal Article, PUBLISHED  DOI
Nagar, S., Obaidi, I., Erol, Ö., Pigott, M., Chen, S., Scalabrino, G., Choi, Y.H., Sheridan, H., Carty, M. and Walsh, J., Metabolomics-guided identification of IFN-ß modulating metabolites in Cladonia portentosa: Effects of geographical origin and extraction methods, Frontiers in Molecular Biosciences, 13, 2026, p1970333-, Journal Article, PUBLISHED
  

Page 1 of 10
O'Dwyer M, Ryan T, Ryder S, D'Arcy DM, Walsh J. , Innovative Development and Evaluation of Professional Attributes through Integration of Science and Practice at First Year Pharmacy Level , Irish Network of Healthcare Educators Conference, TBSI, Trinity College Dublin, Dublin, Ireland , February 2020, 2020, Oral Presentation, PRESENTED
CG Clerkin, M Matzinger, MA Selo, BN Talbot, JJ Walsh, C Ehrhardt, Nucleophilic substitution reactions of ergothioneine might be a novel xenobiotic deactivation mechanism, 32nd Annual Meeting of the Japanese Society for the Study of Xenobiotics, Tokyo, Japan, 29/11-01/12/2017, 2017, Oral Presentation, PRESENTED
C Ehrhardt, S Nickel, MA Selo, CG Clerkin, JJ Salomon, B Talbot, JJ Walsh, OCTN1-mediated ergothioneine uptake protects lung epithelial cells from tobacco smoke-induced damage, FASEB J, Experimental Biology Meeting 2015, Boston, MA, 28/03-01/04/2015, 29, 2015, pp970.7 , Meeting Abstract, PUBLISHED
Adrian Coogan, Design and synthesis of tubulin-binding agents, and their incorporation into novel dual-acting hybrid molecules targeting the tumour vasculature (Ph.D. Thesis), 2013, Thesis, PUBLISHED
Elaine Breen, The design, synthesis and preliminary evaluation of prodrugs and hybrid drugs with tubulin polymerisation inhibitory activity and anti-proliferative activity (Ph.D. Thesis), 2013, Thesis, PUBLISHED
Ekatherine M. Prokopiou, Preclinical evaluation of novel tumour vasculature disrupting agents (Ph.D. Thesis), 2013, Thesis, PUBLISHED
Deirdre Finn, Studies on the design, synthesis and stability of novel anti-allergy agents, 2012, Thesis, PUBLISHED
Tao Zhang, The synthesis of novel mast cell stabilisers from benzocycloalkanones (Ph.D. Thesis)), Trinity College Dublin, 2010, Thesis, PUBLISHED
Paul O'Byrne, Pharmaceutical stability and prodrug studies on the antidepressant bupropion (Ph.D Thesis), 2010, Thesis, PUBLISHED
James Barlow, Synthesis and pharmacological studies on a novel series of mast cell-stabilising tetrahydronaphthalenes and related compounds (Ph.D. Thesis), 2003, Thesis, PUBLISHED

  


Page 1 of 2
Award Date
Henkel Award (Organic Chemistry) 1988
Deans Award for Innovation in Teaching 2015
Commendation for being shortlisted for a Provost's Teaching Award 2013